Russia’s health minister Mikhail Murashko, in a statement said that nearly 14% of patients who have been administrated the covid-19 vaccine --Sputnik V, reported suffering from side-effects.
One in seven volunteers have complained of side effects including weakness and muscle pain after taking Russia’s highly touted coronavirus vaccine, Russia’s health minister said. Murashko said the symptoms “level off" by the next day. The complications are described in the instructions and are predictable," he said as per reports.
The preliminary results of the human clinical trial were published in the Lancet Journal on September 4. Results from two early‐phase non‐randomised vaccine trials for Sputnik V in a total of 76 people found that two formulations of a two‐part vaccine had a good safety profile with no serious adverse events detected over 42 days, and induce antibody responses in all participants within 21 days.
However, the preliminary results published in the Lancet also listed the adverse effects of the vaccine. “The most common adverse events were pain at the injection site (44/76 participants – 58%), hyperthermia (high temperature – 38/76 – 50%), headache (32/76 – 42%), asthenia (weakness or lack of energy – 21/76 – 28%), and muscle and joint pain (18/76 – 24%)," said the Lancet.
Most adverse events were mild, and no serious adverse events were detected within 42 days of vaccination, the Lancet said. The authors note that these adverse effects are characteristic of those seen with other vaccines, particularly those based on recombinant viral vectors, the Lancet said.
India and Russia are in talks about the vaccine to be made available for Indian population. Upon regulatory approval in India, RDIF, Russia’s sovereign wealth fund will supply 100 million doses of the vaccine to Dr. Reddy’s.